Cardiovascular risk reduction with pioglitazone.
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000077205:Pioglitazone; D012307:Risk Factors; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D016896:Treatment Outcome
D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077205:Pioglitazone